Advancis Pharmacautical enters marketing agreement with Innovex

Share this content:
Advancis Pharmaceutical Corporation has entered into a two-year sales and marketing agreement with Innovex for 75 sales reps to promote Advancis' recently approved cephalosporin antibiotic Keflex (cephalexin). Promotion of Keflex was scheduled to begin in mid-July.
Share this content:
Scroll down to see the next article